IRVINE, Calif., April 8, 2020 /PRNewswire/ -- BIOLASE, Inc.
(NASDAQ: BIOL), a leader in medical devices, today announced that
it expects to join the fight against the coronavirus (COVID-19)
outbreak by teaming up with MEKICS Co. Ltd, an intensive care unit
(ICU) equipment manufacturer, to supply MEKICS's MTV-1000 ICU-grade
portable ventilator through BIOLASE's FDA-registered manufacturing
facility in California. The
MTV-1000 ventilator received FDA authorization for emergency use
during the COVID-19 pandemic.
"In this time of global crisis, it is vital that companies come
together to support the fight against COVID-19, leveraging every
tool available, and that's exactly what we intend to do," said
Todd Norbe, CEO of BIOLASE. "Without
hesitation, we expect to pivot quickly and leverage our
FDA-registered facility for the manufacturing and delivery of the
MTV-1000 ventilator and have already received over $10 million in orders. We expect to continue to
focus our efforts to quickly ramp up production, with the
expectation to double the number of orders over the next few
weeks."
BIOLASE has received authorization to manufacture and supply the
MTV-1000 ventilator under the FDA Emergency Use Authorization and
an exemption from the State of
California to operate, market and produce this critically
needed product. BIOLASE expects to use its years of experience in
manufacturing and distributing FDA-cleared medical equipment to
help supply ventilators and support the global backorder on
ventilators during the COVID-19 crisis.
The BIOLASE and MEKICS collaboration aims to bring the MTV-1000
to the United States for the first
time. The MTV-1000 is a field-tested, ICU-level, portable
ventilator that has pressure-control and an internal positive
end-expiratory pressure (PEEP) feature, which is often required for
COVID-19 patients.
"Collaborating with the team at BIOLASE, who have years of
experience manufacturing, marketing and selling medical equipment
in the United States, is a great
opportunity for us to provide this much-needed product to the U.S.
public," said Jong Cheol Kim, CEO
for MEKICS. "We are doing our very best to meet the demand of the
U.S. market and believe it is an honor to help the American public
in any way we can."
MEKICS Co. Ltd. is a medical equipment company based at 21,
Sangjiseok-gil, Paju-Si, Gyeonggi-do 10911, Korea with 20 years of
experience in manufacturing various respiratory products, including
ventilators.
To place an order, please send an email to Stephen Jang at sjang@biolase.com.
About BIOLASE, Inc.
BIOLASE, Inc. is a medical device company that is a global
market leader in the manufacturing and marketing of proprietary
dental laser systems that enable dentists and dental specialists to
perform a broad range of minimally invasive dental procedures,
including cosmetic, restorative, and surgical applications.
BIOLASE's laser systems are designed to provide clinically
superior, patient-friendly results for many types of common dental
procedures compared to those achieved with traditional instruments.
BIOLASE has sold over 41,000 laser systems to date in over 80
countries around the world.
For updates and information on Waterlase iPlus®, Waterlase
Express™, and laser dentistry, find BIOLASE online at
www.biolase.com, Facebook at www.facebook.com/biolase, Twitter at
www.twitter.com/biolaseinc, LinkedIn at
www.linkedin.com/company/biolase, Instagram at
www.instagram.com/waterlase_laserdentistry, and YouTube at
www.youtube.com/biolasevideos.
BIOLASE®, Waterlase®, Waterlase iPlus® and Epic Hygiene™ are
registered trademarks of BIOLASE, Inc.
SOURCE BIOLASE, Inc.